Uppsala, Sweden – July 15, 2013 - Orexo AB today announced the appointment of Henrik Juuel as the new Executive Vice President and CFO. Henrik Juuel will be a member of the company’s executive management team, succeeding Carl-Johan Blomberg, who will leave Orexo as CFO of the company after successful two year tenure. Carl-Johan will continue to support Orexo and Henrik in a transition period. “On behalf of Orexo, I would like to thank Carl-Johan Blomberg for his engagement and involvement in transforming Orexo in to a commercially focused company over the past years. He has taken important part in ensuring that Orexo is financially strong and well prepared to support the launch of Zubsolv” says Nikolaj Sørensen, President and CEO of Orexo AB. Orexo is entering a new phase with increasing effort towards commercialization of the company’s lead product Zubsolv, approved by the FDA earlier this month for the US market. Henrik Juuel brings extensive relevant experience from senior international management positions within the life science industry, including positions as CFO for NNE Pharmaplan and GN Resound. “Henrik Juuel has an impressive career track, having worked in multiple and increasingly senior positions within different finance functions in the life science industry. His experience from financial management of international commercial operations will be important for the continued success of Orexo AB, as our company continues expanding” says Nikolaj Sørensen, President and CEO of Orexo AB. Henrik Juuel commented “I am honored to be appointed CFO of Orexo, and I look forward to closely working with Nikolaj Sørensen to complete the transformation of Orexo to a commercial company with growing international sales and strong partnerships. I am excited about the company’s future opportunities and be a part of the leadership of Orexo.” For further information, please contact: Nikolaj Sørensen, President and CEO Tel: +46 70-350 78 88, E-mail: nikolaj.sorensen@orexo.com About Orexo Orexo is an emerging specialty pharma company with commercial operations in the United States and R&D in Sweden developing improved treatments using proprietary drug delivery technology. Orexo’s expertise is within the area of reformulation technologies and especially sublingual formulations. The company has a portfolio of revenue-generating US and EU approved products currently marketed under license and a pipeline of several reformulations of approved compounds for areas of unmet medical need. Orexo also has collaboration projects with several international pharmaceutical companies. Orexo, with its headquarters in Sweden, is listed on NASDAQ-OMX. The largest shareholders are Novo A/S and HealthCap. For more information about Orexo please visit www.orexo.com. Orexo is required under the Financial Instruments Trading Act to make the information in this press release public. The information was submitted for publication at 08:55 am CET on July 15, 2013.
Orexo appoints Henrik Juuel as new CFO Uppsala, Sweden –
Top 10 Most Recent News Articles
Crucial Insights for South GA Home Insurance Choices
Understanding the Insurance Jargon Here we go again, dealing with insurance gobbledygook that’s about as clear as mud to most of us. Homeowners in South Georgia are being urged to pay attention to the differences between replacement cost and actual cash value in their insurance policies. This ain't just legalese, folks—it's your protection when disaster strikes in our...
Continue Reading
Roof Replacement Timelines: Key Insights for PA Homeowners
There's no denying it; having a roof over your head is one thing, but knowing when to replace it is a whole other ballgame. In Pennsylvania, where the weather loves to throw curveballs, making the right call on roof replacement can save a heap of trouble down the road. Thanks to Miguel Cornejo and his insights in HelloNation’s latest rundown, we get a clearer picture of...
Continue Reading
SaponiQ Reinvents Body Care with Botanical Soap Bars
Breaking Through with Simple Innovation I'll be the first to say it's not every day you hear about a soap company trying to shake things up in body care like it’s a tech startup, but here’s SaponiQ taking a wild swing at it with their lineup of botanical cleansing bars. These things are whipped up in their own U.S.-based facility using some fancy cold-process...
Continue Reading
Medicare Payment Proposal Faces Doctor Backlash in D.C.
Why Same-Day Medicare Care Matters Imagine you're gasping for breath, struggling to find relief, and then being told to wait weeks for care. It's not just an inconvenience; it's a health hazard. This isn't some arbitrary tale—it's the gritty reality for folks relying on same-day care. A group of docs and advocates recently stormed Capitol Hill sounding the alarm about a...
Continue Reading
FSS Unveils AI Tool to Simplify Bankruptcy Cases
AI Revolution in Bankruptcy Management Alright, folks, there's a fresh breeze blowing in the bankruptcy management world, and it bears the acronym FSS. Financial Software Solutions is rolling out its innovative FSS Intelligence Engine. This little powerhouse aims to turn what used to be a gut-wrenching slog through mountains of paperwork into a slick, automated process....
Continue Reading
Superga and Pasqua's Unlikely Fashion-Vineyard Fusion
Superga and Pasqua: A Fusion of Fashion and Vineyards Here's one for the books: Superga, the storied Italian footwear maestro, teaming up with Pasqua Wines, straight out of Verona’s vineyard heartland. On the surface, it seems a rather odd coupling. One's got rubber soles; the other’s got corks. But they’ve pulled off a daring bedroom switch, creating a...
Continue Reading
Neutonic Sets Sights on U.S. with Walmart Expansion
Neutonic Embarks on Major Expansion with Walmart Well, here we go. Neutonic is stepping up to the big leagues by planting its flag in nearly 1,000 Walmart stores across the U.S. This move lands them right in the thrumming heart of Walmart's new Mood & Mind beverage set. It's about time this brand brings its functional beverages to American shoppers already drained by...
Continue Reading
Hyundai's Record Q3 Sales: SUVs and Hybrids Lead
Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...
Continue Reading
Nelson-Jameson Boosts Cold Storage in California Move
An Icy Boost for the West Coast Dairy Player Every now and then, a company gets its cold storage game just right. Nelson-Jameson has added fresh muscle to its Turlock facility in California, making waves with serious logistical upgrades. The company's dogged pursuit of better operational efficiency in dairy processing isn't just about bragging rights. It's plain old good...
Continue Reading
Vortex Expands UK Reach with Torrent Acquisition Boost
Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...
Continue ReadingTop 5 Most Recently Viewed Articles
Fiberglass Mat Market Growth Driven by Strategic Partnerships
Fiberglass Mat Market Growth Driven by Strategic Partnerships The global fiberglass mat market is on a significant growth trajectory, projected to surge by USD 2.29 billion from 2024 to 2028. This growth aligns with a compound annual growth rate (CAGR) of 5.8% during this timeframe. A notable factor fueling this market expansion is the rapid growth of the construction...
Continue Reading
Hermès International Reveals Liquidity Contract Insights
Overview of Hermès International's Liquidity Contract In the ever-evolving financial landscape, transparency plays a vital role. Hermès International is committed to providing clear and detailed insights into their financial strategies. Recently, the company shared an update regarding its liquidity contract, an agreement established to enhance share trading and maintain...
Continue Reading
Phillips 66 Delivers Impressive Q3 Results with 99% Refining Utilization
Strong Third Quarter Performance by Phillips 66 Phillips 66 (NYSE: PSX) demonstrated remarkable strength in its recent third-quarter results, which prompted the company's shares to rise in premarket trading. The integrated energy giant not only exceeded Wall Street expectations but also reported impressive metrics across various sectors. Key Earnings Highlights In this...
Continue Reading
Fixed vs. Indexed Annuities: What West Texas Retirees Need
Retirement Income Strategy: Navigating the Annuity Maze Alright, folks, it's time to dive into the quirks and quandaries of annuities—those financial instruments that can either cradle your retirement or set you back if you're not careful. In West Texas, annuities might be as common as cowboy hats, but picking between a fixed annuity and an indexed one? That's the real...
Continue Reading
Walgreens Boots Reports Better-Than-Expected Earnings Results
Walgreens Boots Earnings Results Overview Walgreens Boots (NASDAQ: WBA) has reported impressive first quarter earnings, significantly surpassing analysts' expectations. The company achieved earnings per share (EPS) of $0.510, which is $0.12 above the projected EPS of $0.390. This positive performance indicates a strong start to the fiscal year for Walgreens. Revenue...
Continue Reading